Neurology Headlines

arthroplasty, arthritis, rheumatic, ixekizumab, RA, rheumatoid, FDA, Rheum Round-up: Five RA Drugs Compared, Two THA Approaches, and more

Rheum Round-up: TKA Updates, Racial Disparities in Arthroplasty, and more

Here are the top stories recently covered by DocWire News in the rheumatology section. In this edition, read about...
Advertisement

Curated Journal Reading List

Latest Medical Headlines

Consumers Who Avoid Product with Specific Chemicals Can Reduce Risk of Cancer

A study shows that consumers who avoid products containing specific endocrine disruptors can reduce the risk of cancer, reproductive disorders, and thyroid disease. To assess...
video

Cardiovascular MRI Outcomes in Patients Recovered from COVID-19 (Part 2)

In the second part of this two-part conversation, Dr. Payal Kohli, a cardiologist at Cherry Creek Heart in Denver, and a DocWire News Section...

5 Ways to Prevent Disease

COVID-19 has fundamentally changed the world as we know it – possibly forever. While there’s virtually nothing good that’s come from this pandemic –...

COVID-19 Update: Indoor Dining Returns to NYC; Europe Continues to Battle Second Wave; and...

World News: As September winds down, here are the latest COVID-19 numbers, according to statistics aggregator Worldometer. Global Cases: Over 33.9 million. Global Deaths: 1,014,886 Outside...
Secukinumab Does Not Increase Risk of TB Reactivation in Rheumatic Disease Patients

Secukinumab Does Not Increase Risk of TB Reactivation in Rheumatic Disease Patients

Human IgG1κ monoclonal antibody secukinumab used to treat patients with psoriatic arthritis (PsA), psoriasis (PsO), and ankylosing spondylitis was not associated with latent tuberculosis...

Featured Interview

video

MedXChange – Relapsing MS

Advertisement